Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Elan receives FDA approvable letter for ziconotide

June 29, 2000

Dual D2 and 5-HT1A receptor partial agonists claimed for depression and anxiety

June 29, 2000

Sanofi-Synthelabo synthesizes new compounds for GABAergic transmission-associated disorders

June 29, 2000

CEP-1347 characterized at medicinal chemistry meeting as potential antiparkinsonian

June 29, 2000

Panacea enters agreements with Loyola covering Lewy body disorders

June 29, 2000

Riluzole + alpha-tocopherol delays progression of ALS more frequently than riluzole alone

June 28, 2000

BASF joins in search for therapeutically useful PARP inhibitors

June 28, 2000

SM-31900 emerges as a promising therapeutic for stroke

June 28, 2000

Estrogen fails to alter cognition, mood or cerebral blood flow in Alzheimer's patients

June 28, 2000

Neurocrine Biosciences presents new CRF receptor antagonists

June 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...